by Perfectus Biomed | News
[et_pb_section][et_pb_row][et_pb_text]
The Government have shared information on How to place a Coronavirus (COVID-19) test kit on the market and guidance for Exemptions from Devices regulations during the coronavirus (COVID-19) outbreak.
As we face this...
by Perfectus Biomed | COVID-19, News
As the global pandemic persists, Perfectus Biomed continues efficacy testing of disinfectants and healthcare products against Coronavirus.
The coronavirus pandemic has required the disinfectant and biocides industry to react quickly to the...
by Perfectus Biomed | Company Update, News
Perfectus Biomed provide molecular support in addition to our typical culture-based studies, providing cell line authentication, pathway targeting and screening of samples for the presence of pathogenic viruses and bacteria. Molecular assays include:
Cell...
by Perfectus Biomed | Company Update, News
Perfectus Biomed are
pleased to officially announce that the United Kingdom Accreditation Service
(UKAS) have granted an Extension to Scope to our ISO 17025 schedule of
accreditation for biofilm testing. The extension includes the Single Tube
Method with Staphylococcus...
by Perfectus Biomed | Company Update, News
Perfectus
Biomed are excited to announce that we have agreed in principle to a merger with
a US-based laboratory that specialises in customisable tissue models. The merge
will result in an integrated in vitro and ex vivo service offering.
The objectives of the merger are...
by Perfectus Biomed | Company Update, News
We are delighted to announce that our new laboratory, dedicated to our growing cell culture and molecular services, is now up and running!
We are really excited to provide you with a first glance into our new laboratory, which allows us to further support our...
